{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:44:48Z","timestamp":1790811888430,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.omtm.2020.11.016","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T21:32:41Z","timestamp":1606944761000},"page":"287-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Efficacy of AAV8-hUGT1A1\u00a0with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Xiaoxia","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sem J.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysbeth","family":"ten Bloemendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Duijst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.","family":"de Waart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bortolussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Collaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Oude Elferink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F.","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mingozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ronzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piter J.","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.11.016_bib1","first-page":"169","article-title":"Congenital familial nonhemolytic jaundice with kernicterus","volume":"10","author":"Crigler","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2020.11.016_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-8278(02)00359-8","article-title":"Inherited disorders of bilirubin metabolism","volume":"38","author":"Bosma","year":"2003","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2020.11.016_bib3","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2014.03.047","article-title":"Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences","volume":"146","author":"Erlinger","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtm.2020.11.016_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00431-005-0055-2","article-title":"Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease","volume":"165","author":"Strauss","year":"2006","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.omtm.2020.11.016_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for Crigler-Najjar syndrome type 1: report of a world registry","volume":"24","author":"van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2020.11.016_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1499-3872(12)60222-7","article-title":"Liver transplantation in Crigler-Najjar syndrome type I disease","volume":"11","author":"Tu","year":"2012","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.omtm.2020.11.016_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2020.11.016_bib8","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B gene therapy with a high-specific-activity factor IX variant","volume":"377","author":"George","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.11.016_bib9","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.11.016_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging issues in AAV-mediated in\u00a0vivo gene therapy","volume":"8","author":"Colella","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.11.016_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/hum.2013.233","article-title":"Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar syndrome","volume":"25","author":"Bortolussi","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/jgm.1343","article-title":"Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2\/8 vectors","volume":"11","author":"Flageul","year":"2009","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2020.11.016_bib13","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/jmv.23818","article-title":"The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals","volume":"86","author":"Mimuro","year":"2014","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.omtm.2020.11.016_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/hum.2018.098","article-title":"Age-related seroprevalence of antibodies against AAV-LK03 in a UK population cohort","volume":"30","author":"Perocheau","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/hum.2019.143","article-title":"Prevalence and relevance of pre-existing anti-adeno-associated virus immunity in the context of gene therapy for Crigler-Najjar syndrome","volume":"30","author":"Aronson","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib16","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2014-09-599266","article-title":"Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg","volume":"125","author":"Biswas","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.11.016_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.omtm.2018.02.003","article-title":"Influence of pre-existing anti-capsid neutralizing and binding antibodies on AAV vector transduction","volume":"9","author":"Fitzpatrick","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.11.016_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.29176","article-title":"Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors","volume":"66","author":"H\u00f6sel","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2020.11.016_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/hgtb.2015.037","article-title":"Determination of anti-adeno-associated virus vector neutralizing antibody titer with an in\u00a0vitro reporter system","volume":"26","author":"Meliani","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.11.016_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.11.016_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"Pa\u00f1eda","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib22","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1038\/mtm.2016.49","article-title":"A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome","volume":"3","author":"Ronzitti","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.11.016_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.omtm.2018.12.011","article-title":"Preclinical development of an AAV8-hUGT1A1 vector for the treatment of Crigler-Najjar syndrome","volume":"12","author":"Collaud","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.11.016_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jgh.14853","article-title":"Disease burden of Crigler-Najjar syndrome: systematic review and future perspectives","volume":"35","author":"Dhawan","year":"2020","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtm.2020.11.016_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MPG.0000000000001843","article-title":"Hepatic parenchymal injury in Crigler-Najjar type I","volume":"66","author":"Mitchell","year":"2018","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.omtm.2020.11.016_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/hum.2017.185","article-title":"AAV8 gene therapy rescues the newborn phenotype of a mouse model of Crigler-Najjar","volume":"29","author":"Greig","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gt.2017.75","article-title":"Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar syndrome type I","volume":"24","author":"Bo\u010dkor","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib28","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","article-title":"Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver","volume":"110","author":"Mingozzi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.11.016_bib29","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","article-title":"Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.11.016_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2020.11.016_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","article-title":"Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition","volume":"20","author":"Umemura","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2020.11.016_bib32","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1038\/s41467-018-06621-3","article-title":"Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration","volume":"9","author":"Meliani","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2020.11.016_bib33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ymthe.2006.01.014","article-title":"Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats","volume":"13","author":"Seppen","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/gt.2011.119","article-title":"AAV vectors transduce hepatocytes in\u00a0vivo as efficiently in cirrhotic as in healthy rat livers","volume":"19","author":"Sobrevals","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib35","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","article-title":"Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors","volume":"76","author":"Zaiss","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.11.016_bib36","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/JVI.01990-07","article-title":"Complement is an essential component of the immune response to adeno-associated virus vectors","volume":"82","author":"Zaiss","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.11.016_bib37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/hum.2013.086","article-title":"Polyinosinic acid blocks adeno-associated virus macrophage endocytosis in\u00a0vitro and enhances adeno-associated virus liver-directed gene therapy in\u00a0vivo","volume":"24","author":"van Dijk","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12016-017-8648-x","article-title":"Sexual dimorphism in innate immunity","volume":"56","author":"Jaillon","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.omtm.2020.11.016_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1556\/APhysiol.96.2009.1.5","article-title":"Gender dependence in the hormone content of the immune cells","volume":"96","author":"Csaba","year":"2009","journal-title":"Acta Physiol. Hung."},{"key":"10.1016\/j.omtm.2020.11.016_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1165\/rcmb.2009-0016OC","article-title":"Macrophages: regulators of sex differences in asthma?","volume":"42","author":"Melgert","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtm.2020.11.016_bib41","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/bloodadvances.2019000380","article-title":"Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates","volume":"3","author":"Salas","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2020.11.016_bib42","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/mt.2011.108","article-title":"A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8","volume":"19","author":"Monteilhet","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","article-title":"IgG-cleaving endopeptidase enables in\u00a0vivo gene therapy in the presence of anti-AAV neutralizing antibodies","volume":"26","author":"Leborgne","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2020.11.016_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/hum.1997.8.1-27","article-title":"Transplantation of Gunn rats with autologous fibroblasts expressing bilirubin UDP-glucuronosyltransferase: correction of genetic deficiency and tumor formation","volume":"8","author":"Seppen","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib45","doi-asserted-by":"crossref","first-page":"ra75","DOI":"10.1126\/scisignal.2000559","article-title":"mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells","volume":"2","author":"Chen","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.omtm.2020.11.016_bib46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.gt.3302681","article-title":"Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats","volume":"13","author":"Seppen","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/gt.2013.69","article-title":"In the rat liver, adenoviral gene transfer efficiency is comparable to AAV","volume":"21","author":"Montenegro-Miranda","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.016_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0676.1990.tb00428.x","article-title":"Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver","volume":"10","author":"James","year":"1990","journal-title":"Liver"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:28:38Z","timestamp":1762421318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120302436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":48,"alternative-id":["S2329050120302436"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.11.016","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of AAV8-hUGT1A1\u00a0with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}